| Identification | Back Directory | [Name]
(±)-(3R*,4S*)-2-Oxo-4-phenyl-3-pyrollidinecarboxylicacid2-[1-(3-bromophenyl)ethylidene]hydrazide | [CAS]
1051487-82-1 | [Synonyms]
AC 264613
2-(DIMETHYLAMINO)ETHYL 2-(2-ETHYLBUTOXY)-2,2-DIPHENYLACETATE
(±)-(3R*,4S*)-2-Oxo-4-phenyl-3-pyrollidinecarboxylicacid2-[1-(3-bromophenyl)ethylidene]hydrazide
3-Pyrrolidinecarboxylic acid, 2-oxo-4-phenyl-, 2-[1-(3-bromophenyl)ethylidene]hydrazide, (3R,4S)-rel- | [Molecular Formula]
C19H18BrN3O2 | [MDL Number]
MFCD18086869 | [MOL File]
1051487-82-1.mol | [Molecular Weight]
400.27 |
| Chemical Properties | Back Directory | [density ]
1.46±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
<40.03mg/ml in DMSO | [form ]
solid | [pka]
10.50±0.40(Predicted) | [color ]
White |
| Hazard Information | Back Directory | [Uses]
AC 264613 is a selective protease-activated receptor 2 (PAR-2) agonist. AC 264613 can be used to investigate the physiological roles of the PAR-?2 receptors. | [Biological Activity]
ac 264613 is a potent agonist of par2 with pec50 value of 7.5 and potencies range from 30 to 100 nm [1, 2].protease-activated receptor 2 (par2) also known as coagulation factor ii (thrombin) receptor-like 1 (f2rl1) or g-protein coupled receptor 11 (gpr11) is expressed in vascular tissue and highly vascular organs and involves in the vascular tone regulation. it has been shown that par2 plays a pivotal role in vessel inflammation and wound healing processes [2].ac 264613 is a selective par2 agonist and has no effect on other pars. when tested with hek 293 t cells (par2 wild type) and knrk cells (transfected with human par2 receptors) for stimulates pi hydrolysis and ca2+ mobilization assays, ac 264613 showed effect with pec50 value of 6.9 and 7.0,respectively [1]. using quickchange mutagenesis manner, nih 3t3 cells were made with ecl2 mutations in q233e, e232r, e232r/q233r, f240s, and f240s/s37p receptors and ac 264613 treatment par2 f240s receptors were constitutively expressed in multiple functional endpoints while had no effect on e232 and q233 mutaions [2].in male sprague-dawley rat model with acute thermal nociception and edema in paw induced by sligrl-nh2 or trypsin, intrapaw administration of ac 264613 induced hind paw edema and thermal hyperalgesia at the doses as low as 30 ng and showed dose-dependent pronociceptive effects [1]. | [in vivo]
AC-264613 exhibits moderate elimination half-live (T1/2=2.5±2.0 h) following i.p. administration (10 mg/kg) in male Sprague-Dawley rats[3]. | [storage]
Store at -20°C | [References]
[1]. gardell, l.r., et al., identification and characterization of novel small-molecule protease-activated receptor 2 agonists. j pharmacol exp ther, 2008. 327(3): p. 799-808.
[2]. ma, j.n. and e.s. burstein, the protease activated receptor 2 (par2) polymorphic variant f240s constitutively activates par2 receptors and potentiates responses to small-molecule par2 agonists. j pharmacol exp ther, 2013. 347(3): p. 697-704. |
|
| Company Name: |
|
| Tel: |
821-50328103-801 18930552037 |
| Website: |
https://www.chemicalbook.com/ShowSupplierProductsList13285/0.htm |
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
R&D Systems, Inc
|
| Tel: |
18003437475 18003437475 |
| Website: |
www.rndsystems.com |
|